012790 — Sinil Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual balance sheet for Sinil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,593	20,870	23,354	23,419	33,713
Net Total Accounts Receivable
Net Total Receivables	21,192	20,721	23,713	22,845	20,839
Total Inventory
Prepaid Expenses
Total Current Assets	52,772	58,427	67,280	68,787	77,449
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32,150	30,999	35,744	41,916	44,789
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	124,810	128,974	142,832	152,460	165,861
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,387	12,023	15,959	14,145	16,453
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	17,326	15,777	19,554	17,565	19,356
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	107,484	113,196	123,277	134,895	146,506
Total Liabilities & Shareholders' Equity	124,810	128,974	142,832	152,460	165,861
Total Common Shares Outstanding